Condition
Metastatic Castrate Resistant Prostate Cancer (mCRPC) clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Metastatic Castrate Resistant Prostate Cancer (mCRPC) clinical trials that are recruiting, at sites in 4 countries (most in Canada (1), Germany (1), Switzerland (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 4Countries
Newest Metastatic Castrate Resistant Prostate Cancer (mCRPC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SX-682 combined with apalutamide for advanced prostate cancer no longer responding to hormone therapy. | Phase 1/2 | Bellinzona and 3 other locations | Recruiting | Jun 3, 2025 |
| Personalized versus fixed‑dose Lutetium‑177 PSMA therapy for metastatic castration‑resistant prostate cancer | Phase 1 | Québec, Quebec | Recruiting | Apr 24, 2025 |
| Impact of 177Lu-PSMA therapy on kidney function in prostate cancer patients | — | Munich | Recruiting | Dec 6, 2024 |
All recruiting trials (3)
-
SX-682 combined with apalutamide for advanced prostate cancer no longer responding to hormone therapy.
This trial will test whether adding SX-682 to apalutamide helps men with metastatic castration‑resistant prostate cancer who have progressed after another next‑generation antiandrogen.
-
Personalized versus fixed‑dose Lutetium‑177 PSMA therapy for metastatic castration‑resistant prostate cancer
This study will test whether personalizing Lutetium‑177 PSMA dosing using kidney dosimetry lets men with metastatic castration‑resistant prostate cancer safely receive higher treatment activity than the standard fixed dosing.
-
Impact of 177Lu-PSMA therapy on kidney function in prostate cancer patients
This study is testing how a new prostate cancer treatment affects kidney function in men with advanced prostate cancer over five years.
Related topics
Quick answers
How many Metastatic Castrate Resistant Prostate Cancer (mCRPC) clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Canada (1 trial), Germany (1 trial), Switzerland (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.